Two Sigma Investments, LP Collegium Pharmaceutical, Inc Transaction History

Two Sigma Investments, LP

$42.3 Billion
Q3 2024

A detailed history of Two Sigma Investments, LP transactions in Collegium Pharmaceutical, Inc stock. As of the latest transaction made, Two Sigma Investments, LP holds 206,405 shares of COLL stock, worth $6.34 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares

206,405

Previous 254,773 18.98%

Holding current value

$6.34 Million

Previous $8.2 Million 2.78%

% of portfolio

0.02%

Previous 0.02%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$31.4 - $39.07 $1.52 Million - $1.89 Million	-48,368 Reduced 18.98%	206,405 $7.98 Million
Q2 2024 Aug 14, 2024	BUY	$31.36 - $39.99 $908,405 - $1.16 Million	28,967 Added 12.83%	254,773 $8.2 Million
Q1 2024 May 15, 2024	SELL	$31.23 - $40.91 $1.06 Million - $1.39 Million	-34,006 Reduced 13.09%	225,806 $8.77 Million
Q4 2023 Feb 14, 2024	SELL	$21.16 - $30.8 $1.89 Million - $2.75 Million	-89,194 Reduced 25.56%	259,812 $8 Million
Q3 2023 Nov 14, 2023	SELL	$21.23 - $24.28 $352,757 - $403,436	-16,616 Reduced 4.54%	349,006 $7.8 Million
Q2 2023 Aug 14, 2023	BUY	$21.06 - $24.0 $135,057 - $153,912	6,413 Added 1.79%	365,622 $7.86 Million
Q1 2023 May 15, 2023	BUY	$23.0 - $29.88 $5.65 Million - $7.34 Million	245,663 Added 216.36%	359,209 $8.62 Million
Q4 2022 Feb 14, 2023	BUY	$16.14 - $23.55 $1.83 Million - $2.67 Million	113,546 New	113,546 $2.63 Million
Q2 2022 Aug 15, 2022	SELL	$14.22 - $20.88 $408,597 - $599,965	-28,734 Closed	0 $0
Q1 2022 May 16, 2022	BUY	$17.2 - $22.5 $494,224 - $646,515	28,734 New	28,734 $585,000
Q3 2021 Nov 15, 2021	SELL	$17.75 - $25.39 $740,778 - $1.06 Million	-41,734 Closed	0 $0
Q2 2021 Aug 16, 2021	SELL	$21.74 - $25.28 $16,826 - $19,566	-774 Reduced 1.82%	41,734 $987,000
Q1 2021 May 17, 2021	BUY	$19.25 - $26.1 $818,279 - $1.11 Million	42,508 New	42,508 $1.01 Million
Q3 2020 Nov 16, 2020	SELL	$15.78 - $20.82 $1.78 Million - $2.34 Million	-112,538 Closed	0 $0
Q2 2020 Aug 14, 2020	SELL	$15.49 - $23.51 $1.07 Million - $1.63 Million	-69,375 Reduced 38.14%	112,538 $1.97 Million
Q1 2020 May 15, 2020	BUY	$13.89 - $25.45 $1.65 Million - $3.03 Million	118,977 Added 189.04%	181,913 $2.97 Million
Q4 2019 Feb 14, 2020	BUY	$10.7 - $22.24 $673,415 - $1.4 Million	62,936 New	62,936 $1.3 Million
Q2 2019 Aug 14, 2019	SELL	$10.62 - $16.59 $733,544 - $1.15 Million	-69,072 Closed	0 $0
Q1 2019 May 15, 2019	BUY	$13.58 - $18.72 $937,997 - $1.29 Million	69,072 New	69,072 $1.05 Million
Q4 2018 Feb 14, 2019	SELL	$14.78 - $19.68 $3.37 Million - $4.49 Million	-228,319 Closed	0 $0
Q3 2018 Nov 14, 2018	BUY	$14.16 - $24.3 $3.23 Million - $5.55 Million	228,319 New	228,319 $3.37 Million
Q2 2018 Aug 14, 2018	SELL	$21.79 - $28.29 $224,153 - $291,019	-10,287 Closed	0 $0
Q1 2018 May 15, 2018	SELL	$18.15 - $29.21 $969,863 - $1.56 Million	-53,436 Reduced 83.86%	10,287 $263,000
Q4 2017 Feb 14, 2018	BUY	$9.3 - $19.14 $592,623 - $1.22 Million	63,723	63,723 $1.18 Million

Others Institutions Holding COLL

# of Institutions

256

Shares Held

38.6M

Call Options Held

100K

Put Options Held

21.1K

View Full List

About COLLEGIUM PHARMACEUTICAL, INC

Ticker COLL
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 34,126,200
Market Cap $1.05B
Description
Collegium Pharmaceutical, Inc., a specialty pharmaceutical company, develops and commercializes medicines for pain management. Its portfolio includes Xtampza ER, an abuse-deterrent, extended-release, oral formulation of oxycodone; Nucynta ER and Nucynta IR, which are extended-release and immediate-release formulations of tapentadol; and Xtampza ...

More about COLL

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Two Sigma Investments, LP, based on Form 13F filings with the SEC.

News

Stay updated on Two Sigma Investments, LP with notifications on news.

Account

Two Sigma Investments, LP Collegium Pharmaceutical, Inc Transaction History